comparemela.com
  1. Home
  2. Live Updates
  3. Infinity Chief Medical Officer - Breaking News

Latest Breaking News On - Infinity chief medical officer - Page 1 : comparemela.com

Infinity Pharmaceuticals Provides Additional Information on MARIO-8 Study Evaluating Eganelisib in Combination with the PD-1 Targeted Checkpoint Inhibitor Pembrolizumab in Patients with Squamous Cell Cancer of the Head and Neck

CAMBRIDGE - Infinity Pharmaceuticals, Inc. , a clinical-stage biotechnology company developing eganelisib, a first-in-class, oral, immuno-oncology macrophage reprogramming drug candidate, announced.

United kingdomEzra cohenRobert ilariaMelissa hackelInfinity pharmaceuticals incMorrow sodaliClinical programPharma incInfinity pharmaceuticalsInstitutional shareholder services incLewis co glassDrug administrationChief medicalInfinity chief medical officerInfinity mergerClinical program update

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.